DNA repair assay for tumor response prediction in cervical cancer to radiotherapy
Not Applicable
- Conditions
- Health Condition 1: C539- Malignant neoplasm of cervix uteri, unspecified
- Registration Number
- CTRI/2024/07/069714
- Lead Sponsor
- Indian Council of Medical Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Diagnosed with cervical cancer.
2. Planned to undergo chemo-radiotherapy.
3. Age over 18 years old.
4. Able to give informed consent.
Exclusion Criteria
1. prior cancer surgery
2. secondary cancer
3. metastasis
4. non-conventional treatment
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Establishment of a functional DSB repair fluorescent assay on a chip that provides a rapid and reliable method for detecting DNA damage and repair activity in cells, compared to traditional methods.Timepoint: One time point
- Secondary Outcome Measures
Name Time Method Predictive biomarkers for cancer treatment outcomes, offering insights into personalized medicine and the improvement of patient care.Timepoint: One time point